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Abstract
Background: The purpose of this study was to extend prior studies of molecular detection of
Brugia malayi DNA in vector (Aedes aegypti- Liverpool) and non-vector (Culex pipiens) mosquitoes
at different times after ingestion of infected blood.
Results: Parasite DNA was detected over a two week time course in 96% of pooled thoraces of
vector mosquitoes. In contrast, parasite DNA was detected in only 24% of thorax pools from non-
vectors; parasite DNA was detected in 56% of midgut pools and 47% of abdomen pools from non-
vectors. Parasite DNA was detected in vectors in the head immediately after the blood meal and
after 14 days. Parasite DNA was also detected in feces and excreta of the vector and non-vector
mosquitoes which could potentially confound results obtained with field samples. However, co-
housing experiments failed to demonstrate transfer of parasite DNA from infected to non-infected
mosquitoes. Parasites were also visualized in mosquito tissues by immunohistololgy using an
antibody to the recombinant filarial antigen Bm14. Parasite larvae were detected consistently after
mf ingestion in Ae. aegypti- Liverpool. Infectious L3s were seen in the head, thorax and abdomen of
vector mosquitoes 14 days after Mf ingestion. In contrast, parasites were only detected by histology
shortly after the blood meal in Cx. pipiens, and these were not labeled by the antibody.
Conclusion: This study provides new information on the distribution of filarial parasites and
parasite DNA in vector and non-vector mosquitoes. This information should be useful for those
involved in designing and interpreting molecular xenomonitoring studies.
Background
Human lymphatic filiarasis (LF) is caused by the mos-
quito-borne filarial nematodes Wuchereria bancrofti, Bru-
gia malayi, and B. timori. These parasites are currently
targeted for elimination by the Global Program for the
Elimination of Lymphatic Filariasis (GPELF), and workers
in this program have reported both achievements and
future challenges to eliminating parasite transmission in
endemic areas [1-3]. One important component of the
elimination program is the ability to estimate infection
prevalence and transmission rates, especially during mass
drug administration (MDA), in order to accurately evalu-
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ate the progress towards the goal of LF transmission inter-
ruption [4]. Molecular detection assays provide sensitive
and specific tools for identifying and distinguishing para-
sites in host populations. Molecular techniques com-
monly used to study LF infection, or exposure, in humans
include the detection of parasite DNA, circulating filarial
antigen, and filarial antibodies in blood samples [5].
Molecular techniques also have been applied to the detec-
tion of filarial worms in mosquitoes, and these primarily
target parasite DNA [6-9].
The detection of parasite DNA in mosquito samples is a
valuable tool for molecular xenomonitoring (MX), but
this does not differentiate parasite developmental stages
or distinguish whether the DNA is from living or dead par-
asites [10-12]. Recently, RNA-based assays have been
developed to detect B. malayi and W. bancrofti in mosqui-
toes [13,14], including the distinction of B. malayi
infected (a constitutive parasite transcript) and infective
mosquitoes (a L3-specific transcript) [14]. However, RNA-
based detection assays have not yet been tested in the field
or incorporated into LF surveillance programs. Vector-par-
asite interactions influence the applicability and interpre-
tation of molecular detection assays used in vector
surveillance studies. There are several factors that should
be carefully considered when using molecular techniques
to investigate parasites within the mosquito intermediate
host, including the (1) various life cycle stages and their
tissue locations, (2) likelihood of parasite development to
the infective stage, i.e., vector competence, and (3) limita-
tions of the particular detection assay, i.e., ability to dis-
tinguish infection stages and living from dead parasites.
The separation of mosquitoes into body regions has been
used to circumvent the inability of some assays to distin-
guish infective-stage parasites. For example, Anopheles spp.
have been divided into two body regions (head/thorax
and abdomen) to provide better estimates of mosquitoes
infected with Plasmodium sporozoites and/or pre-sporo-
zoite stages [15-17] and the heads of blackflies have been
removed (by mass dissection techniques) for the
restricted, head-only, PCR assays targeting Onchocerca
DNA, which is more likely to provide a better estimate of
infective-stage parasites because other developmental
stages generally reside outside of the head [18,19].
The studies conducted herein follow our previous work,
which demonstrated that DNA-based diagnostics are una-
ble to distinguish the developmental stage of LF parasites
or whether parasites are living or dead in the mosquito
[10]. Despite these limitations, there are benefits to using
DNA-based assays over dissection to assess the persistence
of filariasis in populations. Because filarial DNA is detect-
ible for two weeks or longer following a microfilaremic
blood meal in both vector and non-vector mosquitoes, all
anthropophilic mosquitoes can be included in the screen-
ing of mosquitoes for parasite DNA to provide MX data
[10]. Herein, we have further examined the persistence of
filarial parasites and parasite DNA in mosquitoes; we used
a combination of mosquito dissection, immunohistology
and PCR assays to determine the location(s) of filarial
worms and DNA in mosquitoes that are susceptible or
refractory to filarial parasite development. These studies
allowed us to assess the potential value of tissue specific
assays (e.g., mosquito heads only) to estimate the preva-
lence of infective-stage larvae in mosquitoes; we also
investigated the issue of direct mosquito to mosquito
transfer of parasite DNA that could confound MX studies.
Results
Development of B. malayi in Ae. aegypti and Cx. pipiens
Table 1 summarizes the recovery of parasites from dis-
sected mosquitoes. In Ae. aegypti-LVP, 73.6% of the recov-
ered  B. malayi mf at 2 h post ingestion (PI) had
successfully penetrated the midgut, with 49.4% located in
the thorax. At 14 days post ingestion of microfilaremic
blood (DPI), 80% of Ae. aegypti harbored L3s. In contrast,
Table 1: Distribution of B. malayi larvae in vector and non-vector mosquitoes as assessed by dissection.
Time post ingestion Number of parasites recovereda Total wormsa Percentage of mosquitoes harboring 
parasites
Midgut Abdomen Thorax Head
Ae. aegypti-LVP 2 h 23 21 43 n.d. 87 93% (6.2 ± 6.1)b
7 d 0 0 65 0 65 73% (5.9 ± 5.9)
14 d n.d. 7 30 22 59 (20) 80% (3.9 ± 3.2)
Cx. pipiens 2 h 100 4 0 n.d. 104 93% (7.5 ± 7.1)
7 d 0 4 0 0 4 13% (2.0 ± 1.4)
14 d 0 (10) 0 0 0 0 0%
aParasites were observed in mosquito dissections by microscopy at various times after ingestion of microfilaremic blood. Fifteen mosquitoes were 
dissected at each time point, except as noted (n.d., 10, or 20).
bMosquito infection rate (mean intensity ± SD)Parasites & Vectors 2009, 2:56 http://www.parasitesandvectors.com/content/2/1/56
Page 3 of 10
(page number not for citation purposes)
from Cx. pipiens only mf were recovered and 93% of them
were found in the midgut lumen.
B. malayi DNA detection in pooled mosquito body regions
PCR results are summarized in Figure 1. Parasite DNA was
detected in 74% of Ae. aegypti-LVP pooled body region
samples (n = 300) and 36% of Cx. pipiens (n = 300)
pooled body regions tested. These differences were highly
significant (P < 0.0001). In Ae. aegypti-LVP, parasite DNA
was detected in all four body regions with 43, 71, 88, and
96% of heads, midguts, abdomens, and thoraces (n = 75
for each) positive by qPCR, respectively. Parasite DNA
also was detected in all Cx. pipiens body regions, with 17,
24, 47, and 56% of heads, thoraces, abdomens, and mid-
guts (n = 75 for each) positive, respectively. The differ-
ences in the percentage of B. malayi DNA positive samples
were significant between mosquito species in all body
regions (heads, P = 0.001; thoraces, P < 0.0001; abdo-
mens, P < 0.0001) except the midguts (P = 0.09). The
detection of parasite DNA within certain mosquito body
regions was positively or negatively correlated with time.
Specifically, the detection of B. malayi DNA was negatively
correlated with time in 'whole body' Cx. pipiens (r2 = 0.93,
P = 0.0075) and Cx. pipiens midguts (r2 = 0.82, P = 0.034),
and positively correlated with time in Ae. aegypti-LVP
heads (r2 = 0.77, P = 0.05).
B. malayi DNA detection in individual mosquito body 
regions
Individual mosquitoes that were separated into body
regions for DNA detection assays were compared to
results of the pooled mosquito body regions (Fig. 2). Fol-
lowing a microfilaremic blood meal of 191 mf/20 μl
blood, there was no difference in DNA detection between
pooled and individual Ae. aegypti-LVP body regions (P-
values = 0.35-0.61) or between pooled and individual Cx.
pipiens body regions (P-values = 0.78-1.0).
Detection of parasite DNA in mosquito excreta and feces
Figure 3 summarizes the detection of B. malayi DNA in
individual housed mosquitoes and their voided excreta
and feces. All mosquitoes were positive for parasite DNA
immediately (2 hr) after ingesting microfilaremic blood.
From 1-4 DPI all Ae. aegypti-LVP tested positive for para-
site DNA, and three of these (15%) mosquitoes had
detectible B. malayi DNA in their feces. In contrast, 60% of
Cx. pipiens were DNA negative at 4 DPI, but B. malayi DNA
was detected in 100% of Cx. pipiens feces tested at 3-4 DPI.
Of the twenty samples of feces collected over the entire
observation period of 1-4 DPI from each species, B. malayi
DNA was detected in 15 and 65% of Ae. aegypti-LVP and
Cx. pipiens fecal samples, respectively (P = 0.003).
Parasite DNA contamination of B. malayi positive and 
negative mosquitoes
In order to test the possibility that infected mosquitoes
contaminate uninfected mosquitoes while they are
together in the same trap or sampling tube, we housed
uninfected Ae. aegypti-LVP together with Cx. pipiens that
had fed on a microfilaremic gerbil. After 7 days, mosqui-
toes were collected and pooled by species. None of the 17
Ae. aegypti-LVP pools (with 10 mosquitoes per pool) were
positive by real-time PCR. In contrast, 17 of the 21 Cx. pip-
iens pools (with 5 mosquitoes each) were positive. Most
of these samples had relatively high Ct values indicating
small amounts of B. malayi DNA, but 5 pools had higher
Ct values ranging between 29 and 35. Although B. malayi
DNA can be detected in feces of infected mosquitoes, feces
did not cause false positive DNA signals from uninfected
mosquitoes after co-housing.
Detection of Bm14 in mosquito-stage parasites by 
immunohistology
Immunohistology studies were performed to confirm the
dissection results and to better document the fate of B.
Prevalence of B. malayi DNA in pooled samples of experi- mentally infected mosquitoes by body part (head, thorax,  abdomen, and midgut) at different times post ingestion of  microfilaremic blood Figure 1
Prevalence of B. malayi DNA in pooled samples of 
experimentally infected mosquitoes by body part 
(head, thorax, abdomen, and midgut) at different 
times post ingestion of microfilaremic blood. A Ae. 
aegypti-LVP, competent B. malayi vector B Cx. pipiens, B. 
malayi non-vector.Parasites & Vectors 2009, 2:56 http://www.parasitesandvectors.com/content/2/1/56
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malayi in vector and non-vector mosquitoes. In Ae. aegypti-
LVP, unlabeled mf were detected within the midgut
directly after the bloodmeal (Fig. 4A). Strong-labeling was
observed with the Bm14 antibody after the larvae reached
the thoracic muscles. Thus this antibody can be used to
sensitively detect developing filarial larvae in vectors (Fig.
4B-E). Strongly labeled L3s were observed in all body
parts of Ae. aegypti-LVP at 14 DPI (Fig. 4F-G). L3s were not
confined to the head or the thoracic musculature; they
were also seen in the abdomen, outside of the midgut
(Fig. 4J).
Stretched, intrauterine mf in adult female B. malayi are
usually labeled by the Bm14 antibody (Fig. 5A), but mf
were not labeled in the midgut of Cx. pipiens directly after
the blood meal. No larvae were detected in histological
sections of Cx. pipiens at later times points (Fig. 5C, D).
Dead and/or dying larvae in the thorax of Brugia refractory
Ae. aegypti-RKF were not labeled by Bm14 (Fig. 5G, I, J). In
contrast, developing larvae in Ae. aegypti-LVP were always
strongly labeled at the same time points (Fig. 5F, H).
These results suggest that the anti-Bm14 antibody specifi-
cally detects viable and developing B. malayi larvae in vec-
tors.
Discussion
The application of molecular assays to detect parasites
within vectors is influenced by the vector-parasite interac-
tion. In these studies, we analyzed the detection of filarial
worms in susceptible and refractory mosquitoes by target-
ing parasite DNA or protein in molecular assays. The three
mosquito strains examined have very different interac-
tions with B. malayi that were documented in our previous
paper on detection of parasite DNA from living and dead
parasites within mosquitoes [10]. The follow-up studies
discussed herein were designed to investigate: (1) the
mosquito body region(s) containing the persistently
detected parasite DNA within Cx. pipiens (in this mos-
quito species mf are seldom able to migrate out of the
midgut lumen), and (2) the detection of parasite proteins
as larvae develop in susceptible and refractory mosqui-
toes.
Comparison of B. malayi DNA prevalence in pooled and individually tested mosquito body parts Figure 2
Comparison of B. malayi DNA prevalence in pooled and individually tested mosquito body parts. A Ae. aegypti-
LVP body parts were tested in pools of four. B Ae. aegypti-LVP body parts individually tested for parasite DNA. C Cx. pipiens 
body parts tested in pools of four. D Cx. pipiens body parts individually tested for B. malayi DNA.Parasites & Vectors 2009, 2:56 http://www.parasitesandvectors.com/content/2/1/56
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Separation of mosquitoes into body regions (head, tho-
rax, abdomen, and midgut) prior to PCR assays provided
further details on the location of detectible parasite DNA
within mosquitoes. In both vector Ae. aegypti-LVP and
non-vector Cx. pipiens, the head region had the lowest par-
asite DNA detection rates (43 and 17% respectively) when
all time points are considered. However, there was a strik-
ing difference at 14 days when nearly 100% of pools of Ae.
aegypti-LVP heads and very few pools of Cx. pipiens heads
contained parasite DNA. This finding correlates well with
infectivity rates at that time point. Although DNA detec-
tion in mosquito heads might provide a better estimate of
infectivity rates than DNA detection in whole mosquitoes
(Fig. 2), we do not advocate separating heads for this pur-
pose in field studies, because false positive and false neg-
ative infectivity signals are likely to be high with this
approach. Because PCR can detect DNA from live or dead
parasites from any developmental stage, heads could be
falsely positive (without L3s being present) because of
remnants of ingested mf (especially in mosquitoes with
armed cibarial and/or pharyngeal pumps). Heads could
provide a false negative infectivity signal when mosqui-
toes contain L3s in other body parts. Our results and prior
studies [20] have shown that L3s are not restricted to the
head.
B. malayi DNA also was not restricted to the midgut in Cx.
pipiens. Although most mf do not leave the Cx. pipiens
midgut lumen, mf are sometimes detected outside of the
midgut by dissection (Table 1 and Erickson and Chris-
tensen, unpublished data). Although these few mf that do
penetrate the midgut epithelium could be the source of
parasite DNA outside of the Cx. pipiens midgut, an alterna-
tive explanation was also examined. In compatible vec-
tors, the majority of mf penetrate the midgut epithelium
very quickly (within 1.5 h) after ingestion [21], and those
that are unable to penetrate remain within the midgut
lumen and are destined for digestion and/or defecation.
This is in agreement with our observation that at 2 h PI
almost 50% of mf were recovered from the thorax. In par-
asite-vector pairs that limit or prevent mf penetration of
the mosquito midgut (e.g., Brugia--Cx. pipiens and certain
Wuchereria--Culex  spp. interactions) [22-25], parasite
material is likely to be shed in mosquito feces. To test the
hypothesis that DNA detected outside of the midgut is
due to parasite DNA on exterior mosquito surfaces,
excreta and feces from Ae. aegypti and Cx. pipiens were
examined for parasite DNA. B. malayi DNA was detected
in voided materials of both species, but significantly more
Cx. pipiens had detectible parasite DNA in their excreta
and feces following a microfilaremic blood meal (Fig 3).
Although external contamination could cause false posi-
tive PCR results, our mosquito co-housing results suggest
that cross-contamination is probably uncommon.
However, to prevent cross-contamination, the following
steps are recommended for processing wild-caught mos-
quitoes: (1) Immediately kill mosquitoes to limit mos-
quito-mosquito contact, especially if blood engorged
mosquitoes are present; (2) When killing mosquitoes,
avoid methods of slow death in which the mosquito host
is killed and parasites are not, because it is possible for L3s
to escape the body of living, dead, and dying mosquitoes,
especially if mosquitoes come in contact with aqueous
fluids [26-28]; (3) Pool mosquitoes as soon as possible
after collection; (4) When sorting mosquitoes into pools,
tools such as forceps and brushes should not pierce the
mosquito body; and (5) Mosquito sampling should be
restricted to whole females (head, thorax and abdomen
intact). This will reduce error that could be introduced by
testing random body parts from unidentified individuals.
Immunohistochemistry provides an alternative approach
to detecting and studying parasite migration and develop-
ment in mosquitoes; several studies have used this
approach with antibodies to Plasmodium  circumsporo-
zoite protein (CSP) [16,29-31]. Most immunodiagnostic
research on filariasis has focused on the parasite stages
that occur within the vertebrate host [32,33], and this
work has produced sensitive and specific diagnostic tests
for Bancroftian and brugian filariasis [5,34,35]. In con-
Detection of B. malayi DNA in mosquito feces Figure 3
Detection of B. malayi DNA in mosquito feces. A 
Prevalence of parasite DNA in individually housed Ae. aegypti-
LVP and their feces. B Prevalence of parasite DNA in individ-
ually housed Cx. pipiens and their feces. Sample number is 
indicated above each bar.Parasites & Vectors 2009, 2:56 http://www.parasitesandvectors.com/content/2/1/56
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trast, few studies have examined antigen detection as a
method for identifying and distinguishing LF parasites in
mosquitoes. A monoclonal antibody raised against B.
malayi L3s (NEB-D1E5) is specific to a B. malayi L3 surface
antigen and distinguishes B. malayi L3s from infective-
stage larvae of other filarial worms apart from B. timori
[36,37]. In the current study, antibodies to recombinant
B. malayi antigen Bm14 [38,39] were used to detect this
protein in filarial larvae in mosquitoes. Bm14 was
detected in mf and all other developmental stages of par-
asites in the competent vector, Ae. aegypti-LVP. In contrast,
the protein was not detected in parasites present in non-
vector Cx. pipiens (harboring mf in the midgut), or Ae.
aegypti-RKF (harboring parasites that developmentally
arrest as L1s which then die within mosquito muscle
cells). These results suggest that Bm14 may be a specific
biomarker for viable filarial parasites in mosquitoes.
Conclusion
Improved methods are needed for assessing changes in
mosquito infection and infectivity rates in the context of
LF control/elimination programs. As infection rates in
humans and vectors decrease following MDA, increased
numbers of mosquitoes must be tested to accurately esti-
mate parasite prevalence [40]. This makes dissection
impractical, and favors use of molecular detection assays
with pooled mosquitoes. This study provides new infor-
mation on the persistence of filarial worm DNA in non-
vectors that has practical implications for MX studies
regarding methods for processing field-caught mosqui-
toes and for interpreting MX data. Additional studies are
needed to determine whether the presence of Bm14 anti-
gen is a reliable marker for viable filarial worms in pooled
mosquito samples. Although this study focused on B.
malayi, the findings may be of interest to scientists and
Immunohistological detection of B. malayi larvae in Ae. aegypti-LVP using polyclonal antibody to recombinant antigen Bm14 Figure 4
Immunohistological detection of B. malayi larvae in Ae. aegypti-LVP using polyclonal antibody to recombinant 
antigen Bm14. A Non-stained mf (arrow) in the midgut at 1 DPI: B Longitudinal section of a stained L1 in the thorax muscles 
at 1 DPI: C Cross-section of a stained larva at 3 DPI: D Multiple cross-sections of strongly labeled L2s (arrow) at 7 DPI in the 
thorax. E Cross-sections of two strongly labeled L2s with body cavity and developing intestine at 7 DPI: F Overview of the 
head with 4 cross-sections of strongly labeled L3s (arrow) at 14 DPI: G Cross-section of 2 well stained larvae close to the 
mosquito eye. H Labeled L3 at 14 DPI in the mosquito mouthparts. I Multiple strongly labeled L3s (arrows) in the thorax. J 
Strongly labeled L3 in the abdomen. (bm, blood meal; ce, compound eye; de, developing egg; tm, thorax muscles; mg, midgut; 
um, uterus membrane). Scale bars: A-C, E 25 μm; D, F-J 50 μm.
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programs that use molecular techniques to detect other
pathogens (helminths, viruses, or protozoa) in vectors.
Materials and methods
Mosquito maintenance and parasite exposures
Mosquitoes used for these studies were obtained from col-
onies of Aedes aegypti (black-eyed, Liverpool strain; LVP),
Ae. aegypti (Rockefeller strain; RKF) and Culex pipiens pipi-
ens (Iowa strain) maintained at the University of Wiscon-
sin-Madison, as previously described [21,41]. These
mosquitoes differ in their vector competence for B. malayi.
Ae. aegypti-LVP support the development of B. malayi from
mf to L3s, but parasites do not develop in Cx. pipiens,
because mf do not penetrate the midgut epithelium. In Ae.
aegypti-RKF, mf penetrate the mosquito midgut and
migrate into thoracic muscles where they fail to develop to
L2s. This mosquito strain was only used for comparison in
the immunohistology experiments. Four- to seven-day-
old mosquitoes were sucrose starved ~14 h prior to blood
feeding. Mosquitoes were exposed to B. malayi by blood
feeding on microfilaremic cat blood in a water-jacketed
membrane feeder fitted with a parafilm membrane [42].
Mosquitoes also were blood fed on uninfected gerbils
(Meriones unguiculatus) to serve as parasite-negative,
blood-fed controls. Engorged mosquitoes were sorted and
maintained in the laboratory.
Laboratory animals were handled according to guidelines
approved by the Animal Care Committee at the University
of Wisconsin-Madison. The mf densities of B. malayi-
infected cat blood obtained from the NIAID Filariasis
Research Reagent Repository Center http://www.filariasis
center.org used in these studies ranged from 24-191 mf/
20 μl blood.
Mosquito dissection
Five mosquitoes were dissected at 2 hr, 7 d, and 14 d post
ingestion of microfilaremic blood (PI) to estimate the
mean intensity of infection, and to record the stage of B.
malayi  development. Individual mosquitoes were sepa-
Immunohistological detection of B. malayi larvae in the uterus of adult B. malayi or in experimentally infected mosquitoes using  polyclonal antibody to recombinant antigen Bm14 Figure 5
Immunohistological detection of B. malayi larvae in the uterus of adult B. malayi or in experimentally infected 
mosquitoes using polyclonal antibody to recombinant antigen Bm14. A The antibody labeled intra-uterine, stretched 
mf in an adult female B. malayi worm. B Multiple unlabeled mf in the midgut of Cx. pipiens at 2 h PI: C Overview of the head and 
parts of the thorax at 14 DPI negative for B. malayi larvae. D Abdomen of Cx. pipiens at 3 DPI without any visible developing B. 
malayi larvae (labeled or unlabeled). E Magnified, unlabeled mf in the midgut of Cx. pipiens at 2 h PI: F Section of a labeled L1 in 
the thorax muscles of Ae. aegypti-LVP at 1 DPI: G Section of an unlabeled L1 in the thorax of Ae. aegypti-RKF at 1 DPI: H Two 
sections of labeled larvae in the thorax of Ae. aegypti-LVP at 3 DPI: I Section of an unlabeled larva in Ae. aegypti-RKF at 3 DPI. J 
Section of an unlabeled larva in Ae. aegypti-RKF at 7 DPI (compare Fig. 4D). Scale bars: A-D 25 μm; E-F 10 μm.
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rated into head, thorax, midgut, and abdomen, and each
body region was teased apart and individually examined
for parasites by microscopy as previously described [10].
Ae. aegypti-LVP and Cx. pipiens were separated into body
regions (head, thorax, midgut, and abdomen) and placed,
separately or in pools of four, into 2.0 ml microcentrifuge
tubes for parasite DNA detection. To create a pooled sam-
ple, four mosquitoes were separated into body regions,
and the body regions were combined by type into tubes.
For example, four mosquitoes were used to produce one
pool of four heads, one pool of four thoraces, one pool of
four abdomens, and one pool of four midguts. Five
pooled samples were prepared at 2 h, 1, 3, 7, and 14 d PI;
thus, a total of 20 mosquitoes were collected at each time
point for pooled samples. In addition to creating pooled
samples, individual mosquitoes were dissected into body
regions as described above and then placed individually
into tubes. Five individuals were dissected at each time
point to create twenty samples: five tubes contained indi-
vidual heads, five contained a single thorax, five con-
tained an abdomen, and five contained a midgut. These
samples were screened for B. malayi DNA to compare
detection results between individuals and pooled sam-
ples. All samples were cataloged to track a given body
region back to the particular mosquito or pool of mosqui-
toes, allowing the assay results from each body region to
be combined into results for the 'whole mosquito.' For
example, if at least one of the body region samples was
positive; then the 'whole mosquito' was considered posi-
tive and only if all body regions tested negative; then the
'whole mosquito' was considered negative.
Collection of excreta and feces from individual mosquitoes
To examine possible sources of parasite DNA contamina-
tion, mosquitoes were individually housed to collect
material voided by excretion (excreta processed from Mal-
phigian tubules) and defecation (feces containing undi-
gested material from the midgut) [43]. Immediately
following blood engorgement, mosquitoes were individu-
ally housed in 2.0 ml microcentrifuge tubes. Mosquitoes
were maintained for up to 4 DPI by providing 10%
sucrose solution in drops on the mesh-screen top fitted on
each tube. At 24 h intervals, mosquitoes and their voided
matter were collected for DNA extraction. First, the mos-
quito was removed from the collection tube, transferred
to a clean microcentrifuge tube and flash frozen in dry ice.
Then, the collection tube containing the excreta and/or
feces was labeled and also frozen. All samples were stored
at -80°C until DNA extraction. Five mosquitoes of each
species were collected at 2 h and 1-4 d PI, and voided
material was sampled at 1-4 DPI. In addition, the appear-
ance of a blood bolus was recorded for each mosquito to
provide data on the presence or absence of blood meal
remnants within the mosquito midgut. Mosquitoes that
blood fed on uninfected gerbils also were housed individ-
ually and sampled at each time point for negative con-
trols.
Co-housing studies to determine whether B. malayi DNA 
is transferred from infected to uninfected mosquitoes
Uninfected  Ae aegypti were housed together with B.
malayi-infected Cx. pipiens that had fed on two B. malayi-
infected gerbils with microfilaremias of 68 and 146 mf/20
μl blood. Engorged Cx. pipiens were sorted from non-
blood fed mosquitoes, and the engorged mosquitoes were
mixed with non-blood fed Ae. aegypti. Four cartons were
studied with each containing ~60 uninfected Ae. aegypti
and ~40 B. malayi-infected Cx. pipiens. At 7 DPI, mosqui-
toes were collected for qPCR detection of parasite DNA.
Cold anesthetized mosquitoes were sorted by species and
placed in pools of five individuals for Cx. pipiens and
pools of ten individuals for Ae. aegypti. Mosquitoes were
flash frozen on dry ice and stored at -80°C.
DNA extraction and detection
Genomic DNA from pooled mosquitoes or body parts
was extracted using a commercial column method as
described previously [10]. Quantitative real-time PCR was
performed using an MGB probe to detect a 120 bp frag-
ment of the Brugia HhaI repeat [44]. In all real-time PCR
assays, water was used as no-template negative control;
DNA extracted from a pool of non-infected mosquitoes
acted as extraction negative control, and 100 pg of DNA
isolated from adult B. malayi was used as positive control.
Immunohistology
Five mosquitoes of each species were collected at 2 h, 1, 3,
7, and 14 d PI (i.e., the same time points as DNA detection
assays) and stored in 80% ethanol at room temperature
until embedding. Mosquitoes were embedded in paraffin,
and B. malayi larvae were stained using the alkaline phos-
phatase anti-alkaline phosphatase method as described
previously [45]. A polyclonal mouse antibody raised
against recombinant Bm14 protein was used as the pri-
mary antibody for these studies [38].
Statistical Analysis
Data were graphed and analyzed with GraphPad Prism
5.0 http://www.graphpad.com. Fisher's exact tests, with
two-tailed P-values, were used to compare parasite devel-
opment and DNA detection between Ae. aegypti-LVP and
Cx. pipiens. Pearson correlation tests were used to test for
trends in parasite DNA detection over time. Statistical
results were considered significant at P ≤ 0.05.
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